PCSA
Processa Pharmaceuticals, Inc.
Set alert
1.89 USD 0.00 0.00%
1.81 Day range 1.94
1.35 52-week range 9.73
- YTD
- -34.38%
- 1 year
- -78.72%
- Open
- 1.81
- Prev close
- 1.89
- Mkt cap
- 5.29M
- Vol
- 25.37K
- Avg vol
- 94.77K
- EPS
- -4.33
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.81
- High
- 1.94
- Forward P/E
- -0.39
- Beta
- 0.60
- Short ratio
- 2.45
- Inst. own
- 1.49%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.13
- 200-d avg
- 1.62
- 1y target
- 6.00
1Y chart
Closing price and volume
Compare PCSA
Chart and line up PCSA against other symbols or a saved comparison set.
- PCSA Processa Pharmaceuticals, Inc.
1.89
0.00 0.00%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | PCSA | SPY | QQQ |
|---|---|---|---|
| Last price | 1.89 | 755.72 | 690.49 |
| Change | 0.00 | -13.64 | -24.85 |
| Change % | 0.00% | -1.77% | -3.47% |
| Open | 1.81 | 761.38 | 697.13 |
| Day high | 1.94 | 761.46 | 698.63 |
| Day low | 1.81 | 750.36 | 683.45 |
| Previous close | 1.89 | 769.36 | 715.34 |
| Volume | 25.37K | 77.70M | 85.24M |
| Average volume | 94.77K | 41.22M | 34.57M |
| Market cap | 5.29M | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -4.33 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 9.73 | 779.09 | 759.66 |
| 52-week low | 1.35 | 631.97 | 558.28 |
| 1-week return | +4.42% | -0.559233% | -1.97% |
| 1-month return | +15.24% | -0.906075% | -6.66% |
| 3-month return | -7.35% | +1.89% | +1.02% |
| 6-month return | -30.00% | +5.16% | +3.41% |
| Year-to-date return | -34.38% | +10.82% | +12.40% |
| 1-year return | -78.72% | +11.16% | +10.29% |
| 2-year return | -93.46% | +32.90% | +42.71% |
| 50-day moving average | 1.86 | 767.63 | 725.41 |
| 200-day moving average | 2.37 | 728.53 | 679.17 |
| Target price | 6.00 | — | — |
| Beta | 0.597 | 0.00 | 0.00 |
| Short ratio | 2.45 | — | — |
| Institutional ownership | 1.49% | — | — |